ZA811500B - Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them - Google Patents

Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA811500B
ZA811500B ZA00811500A ZA811500A ZA811500B ZA 811500 B ZA811500 B ZA 811500B ZA 00811500 A ZA00811500 A ZA 00811500A ZA 811500 A ZA811500 A ZA 811500A ZA 811500 B ZA811500 B ZA 811500B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
heterocyclic compounds
heterocyclic
Prior art date
Application number
ZA00811500A
Other languages
English (en)
Inventor
G Walther
C Schneider
K Weber
A Fuegner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA811500B publication Critical patent/ZA811500B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02Seven-membered rings
    • C07D267/08Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16[b, f]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA00811500A 1980-03-08 1981-03-06 Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them ZA811500B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ZA811500B true ZA811500B (en) 1982-11-24

Family

ID=6096617

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00811500A ZA811500B (en) 1980-03-08 1981-03-06 Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US4313931A (fr)
EP (1) EP0035749B1 (fr)
JP (1) JPS56139484A (fr)
AU (1) AU535359B2 (fr)
BG (1) BG33886A3 (fr)
CA (1) CA1150253A (fr)
CS (2) CS221288B2 (fr)
DD (1) DD156708A5 (fr)
DE (2) DE3008944A1 (fr)
DK (1) DK154299C (fr)
ES (1) ES500150A0 (fr)
FI (1) FI70898C (fr)
GB (1) GB2071095B (fr)
GR (1) GR74805B (fr)
HK (1) HK63186A (fr)
HU (1) HU180628B (fr)
IE (1) IE51015B1 (fr)
IL (1) IL62309A (fr)
MX (1) MX6869E (fr)
NO (1) NO162073C (fr)
NZ (1) NZ196446A (fr)
PH (1) PH15839A (fr)
PL (1) PL132141B1 (fr)
PT (1) PT72631B (fr)
RO (1) RO81652B (fr)
SU (1) SU1015829A3 (fr)
UA (1) UA8041A1 (fr)
YU (1) YU42557B (fr)
ZA (1) ZA811500B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
WO2003084932A1 (fr) * 2002-04-11 2003-10-16 Konica Minolta Chemical Co., Ltd. Procede de preparation de 6-aminomethyl-6,11-dihydro-5h-dibenz[b,e]azepine
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2522365T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
KR20080034916A (ko) * 2005-07-08 2008-04-22 센주 세이야꾸 가부시키가이샤 에피나스틴을 포함하는 경피 흡수 안과 제제
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13b디하이드로-1H-디벤즈-[c,f]이미다조[1,5-a]-아제핀 염산염의 제조방법
WO2009063504A2 (fr) * 2007-09-24 2009-05-22 Usv Limited Nouvelle modification de cristaux d'épinastine ou de sels de ce composé et processus de préparation de ceux-ci
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789410A (fr) * 1971-10-05 1973-01-15 Akzo Nv Nieuwe imidazolidine derivaten
NL7202963A (fr) * 1972-03-07 1973-09-11
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.

Also Published As

Publication number Publication date
DK154299C (da) 1989-03-28
EP0035749B1 (fr) 1984-06-06
DE3163938D1 (en) 1984-07-12
US4313931A (en) 1982-02-02
ES8301481A1 (es) 1982-12-01
GR74805B (fr) 1984-07-12
IE51015B1 (en) 1986-09-03
JPH0366311B2 (fr) 1991-10-16
HK63186A (en) 1986-09-05
NZ196446A (en) 1984-07-06
FI70898B (fi) 1986-07-18
PT72631B (fr) 1982-12-30
PH15839A (en) 1983-04-08
NO162073C (no) 1989-11-01
AU535359B2 (en) 1984-03-15
RO81652B (ro) 1983-04-30
DE3008944A1 (de) 1981-09-24
GB2071095B (en) 1983-06-02
RO81652A (fr) 1983-04-29
UA8041A1 (uk) 1995-12-26
MX6869E (es) 1986-09-11
DD156708A5 (de) 1982-09-15
DK103581A (da) 1981-09-09
PT72631A (fr) 1981-04-01
NO810762L (no) 1981-09-09
ES500150A0 (es) 1982-12-01
CS221288B2 (en) 1983-04-29
IE810485L (en) 1981-09-08
JPS56139484A (en) 1981-10-30
EP0035749A1 (fr) 1981-09-16
FI810712L (fi) 1981-09-09
HU180628B (en) 1983-03-28
FI70898C (fi) 1986-10-27
GB2071095A (en) 1981-09-16
CA1150253A (fr) 1983-07-19
BG33886A3 (en) 1983-05-16
IL62309A (en) 1984-06-29
YU42557B (en) 1988-10-31
CS410491A3 (en) 1992-05-13
SU1015829A3 (ru) 1983-04-30
PL230036A1 (fr) 1982-05-24
NO162073B (no) 1989-07-24
YU56881A (en) 1983-10-31
PL132141B1 (en) 1985-02-28
IL62309A0 (en) 1981-05-20
DK154299B (da) 1988-10-31
AU6815881A (en) 1981-09-17

Similar Documents

Publication Publication Date Title
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
ZA811500B (en) Heterocyclic compounds,process for their preparation and pharmaceutical compositions containing them
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
IL68618A0 (en) Heterocyclic compounds,their manufacture and pharmaceutical compositions containing them
DE3161838D1 (en) Solid pharmaceutical compositions containing nifedipine, and process for their preparation
DE3160805D1 (en) Antiallergic imidodisulfamides, pharmaceutical compositions containing them and process for their preparation
DE3176154D1 (en) Cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3060861D1 (en) Monophosphonate compounds, process for their preparation and pharmaceutical compositions containing them
DE3167664D1 (en) Pyrazoloindazole derivatives, process for preparing the same, and pharmaceutical composition containing the same
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
DE3064695D1 (en) Heterocyclic compounds, processes for their preparation and compositions containing them
IL61902A (en) Kijanimicin,process for its preparation and pharmaceutical compositions containing it
SG62087G (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
DE3063160D1 (en) Spiro compounds, process for their preparation and pharmaceutical compositions containing them
IL62929A0 (en) Pharmaceutical compositions containing aminophenylpyridine derivatives,certain such novel compounds and their preparation
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
ZA812614B (en) Bis-hydroxybenzyl derivatives, processes for their preparation and pharmaceutical composition containing same
IL62890A0 (en) Alkoxy-acyl carnitines,process for their preparation and pharmaceutical compositions containing same
HK90387A (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
ZA813610B (en) Penicillin derivatives,processes for their preparation and compositions containing them
DE3164432D1 (en) Pyrazolobenzazepines, process for their preparation and pharmaceutical compositions containing them
DE3374863D1 (en) Substituted nitropyrazine compounds, process for their preparation and pharmaceutical compositions containing them
DE3170755D1 (en) Cephalosporins, process for their preparation and pharmaceutical compositions containing them